APA

Ansari J., Hussain S. A., Zarkar A., Tanguay J. S., Bliss J. & Glaholm J. (20081104). Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience. : Oncology reports.

Chicago

Ansari Jawaher, Hussain Syed Anwer, Zarkar Anjali, Tanguay Jacob S, Bliss Julie and Glaholm John. 20081104. Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience. : Oncology reports.

Harvard

Ansari J., Hussain S. A., Zarkar A., Tanguay J. S., Bliss J. and Glaholm J. (20081104). Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience. : Oncology reports.

MLA

Ansari Jawaher, Hussain Syed Anwer, Zarkar Anjali, Tanguay Jacob S, Bliss Julie and Glaholm John. Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience. : Oncology reports. 20081104.